TGFB1 and fibrosis: To characterize the transcriptional changes associated with fibrosis disease development, mRNA and miRNA were purified from the lungs of AAV-TGFβ1- or Bleomycin-treated animals at day 3, 7, 14, 21 and 28 after administration and analyzed by RNA-sequencing.